Chlamydia

Image

About chlamydia

  • Chlamydia is caused by the bacteria Chlamydia trachomatis. 
  • Chlamydia is the most commonly diagnosed bacterial STI in Australia. There were over 100,000 notifications in 2017, most among people aged 15-29.1
  • Untreated chlamydia can cause pelvic inflammatory disease (PID) in people with female reproductive organs and epididymo-orchitis in people with male reproductive organs.
  • Research suggests that genital chlamydia infections can be present for months or years without causing symptoms.2,3
  • Reinfection is common and substantially increases the risk of PID.

Diagnosis and treatment

  • Chlamydia is often asymptomatic and many infections go undiagnosed.4,5
  • Nucleic acid amplification testing is used to diagnose chlamydia. See the Australian STI management guidelines for help with diagnosis and treatment. 
  • Chlamydia is a notifiable condition in Australia, and the state or territorty health department must be notified of a positive case. Click here for more information about notification in your state/territory. 

Follow-up and management

  • Consider testing for other STIs if this did not occur at the initial presentation (see the Australian STI management guidelines for further information).
  • Advise no sexual contact for seven days after treatment is administered, and no sex with partners from the previous six months until they have been tested and treated as appropriate.6
  • Sexual partners from the previous six months should be notified to help prevent reinfection and onward transmission.6 It is the diagnosing clinician’s responsibility to initiate a discussion about partner notification. Click here for further information about partner management. 
  • A test of cure is not routinely recommended, unless the patient is pregnant, or the infection was an anorectal infection treated with azithromycin.6
    A test for reinfection is recommended at three months.6 For further information about organising retesting, click here

For detailed information about chlamydia, including treatment and management:
Australian STI management guidelines: Chlamydia.

 

References

References

  1. The Kirby Institute Annual Surveillance Report 2018, available at: https://kirby.unsw.edu.au/report/hiv-viral-hepatitis-and-sexually-transmissible-infections-australia-annual-surveillance
  2. Fairley CK, Gurrin L, Walker J, Hocking JS. “Doctor, How Long Has My Chlamydia Been There?” Answer: “…. Years”. J Sex Transm Dis. 2007;34(9):727-8.
  3. Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine. Australasian Contact Tracing Guidelines 2016 [updated 2016; cited 2022 16th June]. Available from: http://contacttracing.ashm.org.au/
  4. Peipert JF. Genital Chlamydial Infections. N Engl. 2003;349(25):2424-30.
  5. Gray RT, Callander D, Hocking JS, McGregor S, McManus H, Dyda A, et al. Population-level diagnosis and care cascade for chlamydia in Australia. Sex Transm Infect. 2019:sextrans-2018-053801
  6. Australasian Sexual Health Alliance. Australian STI Management Guidelines for use in Primary Care 2018 [updated December 2021; cited 2022 16th June]. Available from: https://sti.guidelines.org.au/

MoCCA is funded by the National Health and Medical Research Council (APP1150014) and is a collaboration between the University of Melbourne and our project investigators and partner organisations in Victoria, New South Wales and Queensland. Click here for a list of our collaborators.

The information on this website was last updated in June 2024. 

We acknowledge and pay respect to the Traditional Owners of the lands upon which this research is being conducted.

uomlogo